Intensified Doxorubicin-Based Regimen Efficacy in Residual Non-Hodgkin's Lymphoma Disease: Towards a Computationally Supported Treatment Improvement (Q2788513): Difference between revisions
From MaRDI portal
Removed claims |
Changed an Item |
||
| Property / author | |||
| Property / author: Yuri Kogan / rank | |||
Normal rank | |||
| Property / author | |||
| Property / author: Benjamin Ribba / rank | |||
Normal rank | |||
| Property / author | |||
| Property / author: Vladimir Vainstein / rank | |||
Normal rank | |||
| Property / author | |||
| Property / author: Zvia Agur / rank | |||
Normal rank | |||
Revision as of 21:45, 13 February 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intensified Doxorubicin-Based Regimen Efficacy in Residual Non-Hodgkin's Lymphoma Disease: Towards a Computationally Supported Treatment Improvement |
scientific article |
Statements
Intensified Doxorubicin-Based Regimen Efficacy in Residual Non-Hodgkin's Lymphoma Disease: Towards a Computationally Supported Treatment Improvement (English)
0 references
19 February 2016
0 references
mathematical model
0 references
vascular tumour
0 references
avascular tumour
0 references
heterogeneity
0 references
chemotherapy
0 references
non-Hodgkin lymphoma
0 references
CHOP
0 references
doxorubicin
0 references
hybrid cellular automata
0 references
